Physician profile
Joanna Widdows
NPI 1619911070
$5,492.31
in general payments reported to CMS, 2019-2025
32 companies · $725 in 2025
The $725 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $770 · 2020: $740 · 2021: $869 · 2022: $723 · 2023: $781 · 2024: $884 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,389.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $974.03 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $568.40 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $485.69 | 2019-2024 | |
| Lilly USA, LLC | $419.30 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $407.33 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astellas Pharma US INC | $372.92 | 2019-2025 | Veozah |
| Abbvie INC. | $359.44 | 2020-2025 | Ubrelvy, Vraylar, Synthroid |
| Amarin Pharma, INC. | $337.40 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $187.54 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $138.16 | 2023-2025 | Gemtesa |
| Exact Sciences Corporation | $130.56 | 2023-2024 | Cologuard Collection Kit |
| Alk-Abello, INC | $120.98 | 2024-2025 | Grastek, Ragwitek, Odactra |
| Merck Sharp & Dohme LLC | $116.16 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $96.00 | 2020-2023 | |
| Amgen INC. | $86.28 | 2019-2025 | Repatha, Otezla, Repatha |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.32 | 2020-2022 | |
| Inari Medical, INC. | $70.99 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sunovion Pharmaceuticals INC. | $68.47 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.20 | 2020-2021 | |
| Allergan, INC. | $64.14 | 2019-2020 | |
| Nevro Corp. | $57.36 | 2022-2023 | Senza |
| Horizon Therapeutics Plc | $42.57 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $41.32 | 2019-2024 | Xarelto |
| Eisai INC. | $31.67 | 2020-2022 | |
| Esperion Therapeutics, INC. | $31.02 | 2021-2024 | Nexletol |
| Biohaven Pharmaceutical Holding Company LTD. | $24.98 | 2022 | |
| Therapeuticsmd, INC. | $21.67 | 2019 | |
| Almatica Pharma LLC | $19.62 | 2024 | Loreev Xr |
| Amneal Pharmaceuticals LLC | $18.49 | 2022 | |
| Endo Pharmaceuticals INC. | $17.87 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.41 | 2024 | Eliquis |
| Arbor Pharmaceuticals, INC. | $14.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Widdows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.